Asterias Biotherapeutics, Inc. 

CA

  SEC # 1572552

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  3/20/13   —   First EDGAR Filing:  4/3/13   –   Last Filing:  3/20/19  (None in the Past Year) 

Possible Termination of Registration and/or Duty to File Reports per 3/20/19 Form 15

Business Address      On:  3/20/19       [ Map ]		Mailing Address      On:  3/20/19       [ Map ]
6300 Dumbarton Circle Fremont, California  94555 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 510-456-3805		Delaware, U.S.A.		12/31/yy		46-1047971		0001572552		001-36646

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2836 Biological Products, Except Diagnostic Substances 2019 SEC Office of Life Sciences

        

Management
Director   In   CA   Mulroy Michael H. 2017-2019   CA   Arno Andrew 2014-2018   CA   LeBuhn Richard T. 2014-2018   GA   Ricciardi Natale S 2014-2018   CA   Bailey Don M 2016-2018   CA   Cartt Stephen LaHue 2016-2018   CA   Scher Howard Isador 2016-2018   NY   Kingsley Alfred D 2013-2016   MA   Peabody Robert 2014-2016   CA   Lichtinger Pedro 2015-2016   CA   Mohanty Aditya P. 2016   CA   West Michael D 2013-2015   CA   Segall Judith 2014-2015 ↓List Pre-2015 Directors				Officer  Since  Most-Recent Title   In   CA   Mulroy Michael H. 2017 President & CEO 2019   CA   Chavez Ryan Daniel 2016 CFO & General Counsel 2019   MA   Wirth Edward 2015 Chief Medical Officer 2019   CA   Cartt Stephen LaHue 2016 President & CEO 2017   CA   Lebkowski Jane 2013 Chief Scientific Officer 2017   CA   Spink Katharine E. 2013 EVP & COO 2017   CA   Lichtinger Pedro 2014 President & CEO 2016   CA   Erbez Georgia Exec VP & CFO 2015   CA   Segall Judith 2014 Corporate Secretary 2015   MA   Peabody Robert 2013 Chief Financial Officer 2015   CA   West Michael D 2013 VP of Technology Integration 2015 ↓List Pre-2015 Officers

        

        

        

        

Securities
CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2023:   04624N 04624N·10·7     Common Ser A 04624N·01·6     Options 04624N·11·5     W Exp 09/29/201 _________  Classes source:  Form 13F Filings that list Section 13(f) Securities